Daniel Egle
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 45
- HER2/EGFR in Cancer Research 20
- Cancer Treatment and Pharmacology 16
- Lung Cancer Research Studies 5
-
- Breast Cancer Treatment Studies 24
- Co-authors
- Christian Marth (15 shared papers)Heidi Fiegl (6 shared papers)Martin Widschwendter (3 shared papers)Joanne Young (1 shared paper)Peter W. Laird (1 shared paper)Ian Jacobs (1 shared paper)Elisabeth Mueller‐Holzner (1 shared paper)Gilbert Spizzo (1 shared paper)
- Journals
- Cancer Research (13 papers)Journal of Clinical Oncology (12 papers)Annals of Oncology (8 papers)The Breast (5 papers)ESMO Open (5 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Daniel Egle
87 papers receiving 2.4k citations
Daniel Egle's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 526
- Oncology 833
- Molecular Biology 946
- Obstetrics and Gynecology 86
- Pulmonary and Respiratory Medicine 314
Countries citing papers authored by Daniel Egle
This map shows the geographic impact of Daniel Egle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Egle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Egle more than expected).
Fields of papers citing papers by Daniel Egle
This network shows the impact of papers produced by Daniel Egle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Egle. The network helps show where Daniel Egle may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Egle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetic stem cell signature in cancer Hit paper breakdown → | 2006 | 854 |
| 2 | Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study Hit paper breakdown → | 2022 | 216 |
| 3 | 2019 | 155 | |
| 4 | 2020 | 110 | |
| 5 | 2021 | 97 | |
| 6 | 2010 | 81 | |
| 7 | 2012 | 73 | |
| 8 | 2011 | 64 | |
| 9 | 2011 | 58 | |
| 10 | 2011 | 57 | |
| 11 | 2020 | 43 | |
| 12 | 2017 | 42 | |
| 13 | 2013 | 40 | |
| 14 | 2017 | 38 | |
| 15 | 2020 | 37 | |
| 16 | 2017 | 34 | |
| 17 | 2008 | 25 | |
| 18 | 2020 | 24 | |
| 19 | 2018 | 18 | |
| 20 | 2021 | 16 |
About Daniel Egle
Daniel Egle is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 91 papers that have together received 2.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (20 papers), Advanced Breast Cancer Therapies (20 papers), Cancer Treatment and Pharmacology (16 papers), Breast Implant and Reconstruction (6 papers), Estrogen and related hormone effects (5 papers), Lung Cancer Research Studies (5 papers) and Reconstructive Surgery and Microvascular Techniques (5 papers). The work is most often cited by research in Cancer Research (526 citations), Oncology (833 citations), Molecular Biology (946 citations), Obstetrics and Gynecology (86 citations) and Pulmonary and Respiratory Medicine (314 citations). Daniel Egle has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Christian Marth, Heidi Fiegl, Martin Widschwendter, Joanne Young, Peter W. Laird, Ian Jacobs, Elisabeth Mueller‐Holzner, Gilbert Spizzo, Mihaela Campan and Daniel J. Weisenberger. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, The Breast and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.